Matches in Wikidata for { <http://www.wikidata.org/entity/Q96132684> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q96132684 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96132684 description "scientific article published on 02 June 2020" @default.
- Q96132684 description "wetenschappelijk artikel" @default.
- Q96132684 description "наукова стаття, опублікована 2 червня 2020" @default.
- Q96132684 name "Lenalidomide plus rituximab Vs rituximab alone in relapsed or refractory indolent lymphoma: A cost-effectiveness analysis" @default.
- Q96132684 name "Lenalidomide plus rituximab Vs rituximab alone in relapsed or refractory indolent lymphoma: A cost-effectiveness analysis" @default.
- Q96132684 type Item @default.
- Q96132684 label "Lenalidomide plus rituximab Vs rituximab alone in relapsed or refractory indolent lymphoma: A cost-effectiveness analysis" @default.
- Q96132684 label "Lenalidomide plus rituximab Vs rituximab alone in relapsed or refractory indolent lymphoma: A cost-effectiveness analysis" @default.
- Q96132684 prefLabel "Lenalidomide plus rituximab Vs rituximab alone in relapsed or refractory indolent lymphoma: A cost-effectiveness analysis" @default.
- Q96132684 prefLabel "Lenalidomide plus rituximab Vs rituximab alone in relapsed or refractory indolent lymphoma: A cost-effectiveness analysis" @default.
- Q96132684 P1433 Q96132684-38CDAC57-9928-4E65-8216-2F72B7A13E2B @default.
- Q96132684 P1476 Q96132684-CB0FA85D-6799-4E23-B4AE-D92324018F6D @default.
- Q96132684 P2093 Q96132684-25AFA63B-8A19-4378-81CE-7F240BD140AF @default.
- Q96132684 P2093 Q96132684-A37C9C32-CD7F-4765-9163-DFE9491FC55B @default.
- Q96132684 P2093 Q96132684-A658C730-72E7-4C77-A005-A6557E16EEE9 @default.
- Q96132684 P31 Q96132684-9A1E10A5-0785-43AC-B01B-A1E0CB347A60 @default.
- Q96132684 P356 Q96132684-4F20B789-EB13-44D5-B318-46E6007F2805 @default.
- Q96132684 P50 Q96132684-6293E85A-84FB-45C8-83A6-31977557FFDD @default.
- Q96132684 P577 Q96132684-966531AE-BB18-4C1B-B055-33B4F5821F09 @default.
- Q96132684 P698 Q96132684-F4044DE9-A9F1-4F43-BB3D-F99613EDE3C2 @default.
- Q96132684 P921 Q96132684-7508C015-1D7B-4659-A967-BB7CBEB5A29D @default.
- Q96132684 P921 Q96132684-FA4D146F-6584-4DD8-B306-AF1E3ABB55BB @default.
- Q96132684 P932 Q96132684-C69C749E-33EF-4576-9BF0-A7F3C50978A9 @default.
- Q96132684 P356 CAM4.3121 @default.
- Q96132684 P698 32489014 @default.
- Q96132684 P1433 Q27724564 @default.
- Q96132684 P1476 "Lenalidomide plus rituximab Vs rituximab alone in relapsed or refractory indolent lymphoma: A cost-effectiveness analysis" @default.
- Q96132684 P2093 "Dan Xie" @default.
- Q96132684 P2093 "Feng Wen" @default.
- Q96132684 P2093 "Peng-Fei Zhang" @default.
- Q96132684 P31 Q13442814 @default.
- Q96132684 P356 "10.1002/CAM4.3121" @default.
- Q96132684 P50 Q90208672 @default.
- Q96132684 P577 "2020-06-02T00:00:00Z" @default.
- Q96132684 P698 "32489014" @default.
- Q96132684 P921 Q1754768 @default.
- Q96132684 P921 Q412323 @default.
- Q96132684 P932 "7402838" @default.